Approval · Notice of Compliance 4177 · 1996
ACEL-P: Notice of Compliance 4177
Issued March 29, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4177
- Date
- March 29, 1996
- Company
- Wyeth-Ayerst Canada Inc.St. Laurent, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACEL-P | 02215071 | Cancelled Post Market |
Medicinal ingredients
- ACELLULAR PERTUSSIS VACCINE ADSORBED 300 UNIT per 0.5ML